Schaper Benz & Wise Investment Counsel’s AbbVie ABBV Stock Holding History

Schaper Benz & Wise Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Hold	4,581	–	–	0.08%	109
2026 Q1	$996K	Buy	4,581 +64	+1%	+$14.2K	0.08%	110
2025 Q4	$1.03M	Sell	4,517 -1,000	-18%	-$228K	0.07%	106
2025 Q3	$1.28M	Sell	5,517 -687	-11%	-$140K	0.1%	102
2025 Q2	$1.15M	Buy	6,204 +664	+12%	+$123K	0.09%	100
2025 Q1	$1.16M	Sell	5,540 -75	-1%	-$14.6K	0.09%	98
2024 Q4	$998K	Hold	5,615	–	–	0.08%	99
2024 Q3	$1.11M	Hold	5,615	–	–	0.09%	98
2024 Q2	$963K	Sell	5,615 -115	-2%	-$19.1K	0.08%	95
2024 Q1	$1.04M	Buy	5,730 +25	+0.4%	+$4.31K	0.09%	96
2023 Q4	$884K	Hold	5,705	–	–	0.08%	94
2023 Q3	$850K	Sell	5,705 -50	-0.9%	-$7.34K	0.08%	96
2023 Q2	$775K	Hold	5,755	–	–	0.07%	99
2023 Q1	$917K	Sell	5,755 -245	-4%	-$37.5K	0.09%	92
2022 Q4	$970K	Sell	6,000 -355	-6%	-$54.4K	0.1%	92
2022 Q3	$853K	Hold	6,355	–	–	0.1%	92
2022 Q2	$973K	Buy	6,355 +619	+11%	+$94.6K	0.1%	97
2022 Q1	$930K	Buy	5,736 +1,500	+35%	+$218K	0.08%	102
2021 Q4	$574K	Hold	4,236	–	–	0.05%	109
2021 Q3	$457K	Hold	4,236	–	–	0.04%	101
2021 Q2	$477K	Buy	4,236 +325	+8%	+$36.6K	0.04%	100
2021 Q1	$423K	Hold	3,911	–	–	0.04%	102
2020 Q4	$419K	Buy	3,911 +272	+7%	+$26.1K	0.04%	100
2020 Q3	$319K	Sell	3,639 -700	-16%	-$65.9K	0.04%	98
2020 Q2	$426K	Buy	4,339 +8	+0.2%	+$704	0.05%	95
2020 Q1	$330K	Sell	4,331 -2,000	-32%	-$170K	0.05%	95
2019 Q4	$561K	Hold	6,331	–	–	0.07%	88
2019 Q3	$479K	Sell	6,331 -725	-10%	-$49.7K	0.06%	89
2019 Q2	$513K	Sell	7,056 -1,700	-19%	-$134K	0.06%	85
2019 Q1	$706K	Sell	8,756 -2,625	-23%	-$215K	0.09%	86
2018 Q4	$1.05M	Hold	11,381	–	–	0.16%	78
2018 Q3	$1.08M	Sell	11,381 -4,429	-28%	-$420K	0.14%	84
2018 Q2	$1.47M	Hold	15,810	–	–	0.21%	76
2018 Q1	$1.5M	Sell	15,810 -800	-5%	-$87.9K	0.22%	73
2017 Q4	$1.61M	Sell	16,610 -175	-1%	-$16.5K	0.23%	71
2017 Q3	$1.49M	Buy	16,785 +400	+2%	+$30.4K	0.23%	73
2017 Q2	$1.19M	Hold	16,385	–	–	0.19%	76
2017 Q1	$1.07M	Sell	16,385 -965	-6%	-$60.7K	0.18%	78
2016 Q4	$1.09M	Sell	17,350 -2,050	-11%	-$125K	0.19%	74
2016 Q3	$1.22M	Sell	19,400 -750	-4%	-$48.6K	0.22%	72
2016 Q2	$1.25M	Hold	20,150	–	–	0.22%	69
2016 Q1	$1.15M	Hold	20,150	–	–	0.22%	69
2015 Q4	$1.19M	Buy	20,150 +600	+3%	+$34.6K	0.24%	68
2015 Q3	$1.06M	Hold	19,550	–	–	0.22%	67
2015 Q2	$1.31M	Sell	19,550 -1,650	-8%	-$108K	0.26%	67
2015 Q1	$1.24M	Hold	21,200	–	–	0.24%	67
2014 Q4	$1.39M	Sell	21,200 -2,014	-9%	-$127K	0.28%	64
2014 Q3	$1.34M	Sell	23,214 -450	-2%	-$25K	0.28%	65
2014 Q2	$1.34M	Sell	23,664 -1,300	-5%	-$68.2K	0.28%	64
2014 Q1	$1.28M	Sell	24,964 -10,782	-30%	-$545K	0.28%	66
2013 Q4	$1.89M	Sell	35,746 -9,950	-22%	-$489K	0.42%	52
2013 Q3	$2.04M	Sell	45,696 -5,133	-10%	-$228K	0.47%	51
2013 Q2	$2.1M	Buy	+50,829	New	+$2.22M	0.52%	51

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's ABBV Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel held its AbbVie (ABBV) position steady in Q2 2026 at 4,581 shares worth $1.15M. The position accounts for 0.08% of the portfolio, ranked #109.

Schaper Benz & Wise Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.1M in Q2 2013. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Schaper Benz & Wise Investment Counsel held 4,581 shares of AbbVie worth $1.15M as of Q2 2026.
Schaper Benz & Wise Investment Counsel left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.08% of Schaper Benz & Wise Investment Counsel's portfolio in Q2 2026, its #109 holding.
Schaper Benz & Wise Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Schaper Benz & Wise Investment Counsel's AbbVie position peaked at $2.1M in Q2 2013.
1,797 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.